Related changes

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 08:32, 5 June 2024

List of abbreviations:

N: This edit created a new page (also see list of new pages)
m: This is a minor edit
b: This edit was performed by a bot
(±123): The page size changed by this number of bytes

5 June 2024

m 01:34

Classical Hodgkin lymphoma‎ diffhist -6‎ Jwarner talk contribs

m 01:22

Nasopharyngeal carcinoma‎ diffhist -34‎ Jwarner talk contribs

m 01:21

Pancreatic cancer‎ diffhist -2‎ Jwarner talk contribs →‎References

m 01:20

Testicular cancer‎ diffhist -2‎ Jwarner talk contribs →‎References

4 June 2024

m 14:05

Non-small cell lung cancer, nonsquamous‎ diffhist +51‎ Jwarner talk contribs →‎References

1 June 2024

03:36

Mantle cell lymphoma‎ diffhist +1,367‎ Jwarner talk contribs →‎Obinutuzumab monotherapy {{#subobject:7f1090|Regimen=1}}

30 May 2024

23:40

Nasopharyngeal carcinoma‎ diffhist +57‎ Warner-admin talk contribs

			m 23:32		Breast cancer‎‎ 2 changes history -33‎ [Warner-admin‎ (2×)]
			m		23:32 (cur \| prev) -1‎ Warner-admin talk contribs Text replacement - "Mitomycine" to "Mitomycin"
			m		23:12 (cur \| prev) -32‎ Warner-admin talk contribs

			23:22		Diffuse large B-cell lymphoma‎‎ 2 changes history +209‎ [Warner-admin‎; Jwarner‎]
					23:22 (cur \| prev) +9‎ Warner-admin talk contribs
			m		14:13 (cur \| prev) +200‎ Jwarner talk contribs

m 23:15

Ovarian cancer‎ diffhist +9‎ Warner-admin talk contribs

29 May 2024

			11:10		Gastric cancer‎‎ 3 changes history +5,555‎ [Jwarner‎ (3×)]
			m		11:10 (cur \| prev) +2,093‎ Jwarner talk contribs →‎CapeOx & Pembrolizumab {{#subobject:1yhy28\|Regimen=1}}
					11:08 (cur \| prev) +2,178‎ Jwarner talk contribs →‎Cisplatin & Fluorouracil (CF) & Pembrolizumab {{#subobject:25ncw1\|Regimen=1}}
			m		11:07 (cur \| prev) +1,284‎ Jwarner talk contribs

m 00:11

Cervical cancer‎ diffhist +77‎ Jwarner talk contribs →‎References

28 May 2024

m 23:55

Endometrial cancer‎ diffhist +1,049‎ Jwarner talk contribs →‎Radiation therapy {{#subobject:24a846|Regimen=1}}

m 20:04

Prostate cancer‎ diffhist +2,406‎ Jwarner talk contribs →‎ADT {{#subobject:6e0da9|Regimen=1}}

			19:46		Mantle cell lymphoma‎‎ 4 changes history +13,776‎ [Jwarner‎ (4×)]
					19:46 (cur \| prev) +8,011‎ Jwarner talk contribs →‎R-CHOP {{#subobject:ca52ab\|Regimen=1}}
			m		19:40 (cur \| prev) +136‎ Jwarner talk contribs →‎R-CHOP/R-DHAP {{#subobject:989434\|Regimen=1}}
			m		19:39 (cur \| prev) +137‎ Jwarner talk contribs →‎R-CHOP/R-DHAOx {{#subobject:98ox34\|Regimen=1}}
					19:36 (cur \| prev) +5,492‎ Jwarner talk contribs →‎R-CHOP/R-DHAP {{#subobject:989434\|Regimen=1}}

m 15:46

Non-small cell lung cancer, nonsquamous‎ diffhist +2,101‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25|Regimen=1}}

26 May 2024

m 22:08

Non-small cell lung cancer, nonsquamous‎ diffhist +1,382‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25|Regimen=1}}

m 13:25

Gastric cancer‎ diffhist +1,017‎ Jwarner talk contribs →‎Paclitaxel monotherapy {{#subobject:2dcad9|Regimen=1}}

m 12:32

Ovarian cancer‎ diffhist +241‎ Jwarner talk contribs

25 May 2024

			m 17:11		Non-small cell lung cancer, nonsquamous‎‎ 5 changes history +664‎ [Jwarner‎ (5×)]
			m		17:11 (cur \| prev) +986‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25\|Regimen=1}}
			m		15:38 (cur \| prev) +1,379‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25\|Regimen=1}}
			m		12:54 (cur \| prev) 0‎ Jwarner talk contribs →‎Regimen variant #4, 6/200/15 x 6 {{#subobject:7df5c3\|Variant=1}}
			m		11:17 (cur \| prev) -2,613‎ Jwarner talk contribs →‎Bevacizumab monotherapy {{#subobject:75f589\|Regimen=1}}
			m		11:16 (cur \| prev) +912‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) & Bevacizumab {{#subobject:1c2c25\|Regimen=1}}

			m 12:43		Non-small cell lung cancer‎‎ 5 changes history +9,453‎ [Jwarner‎ (5×)]
			m		12:43 (cur \| prev) 0‎ Jwarner talk contribs
			m		12:42 (cur \| prev) +88‎ Jwarner talk contribs
			m		12:42 (cur \| prev) +1,891‎ Jwarner talk contribs →‎Carboplatin & Pemetrexed {{#subobject:920f46\|Regimen=1}}
			m		12:37 (cur \| prev) +1,267‎ Jwarner talk contribs →‎Pembrolizumab monotherapy {{#subobject:430dc7\|Regimen=1}}
			m		12:28 (cur \| prev) +6,207‎ Jwarner talk contribs →‎Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf\|Regimen=1}}

m 10:55

Non-small cell lung cancer, squamous‎ diffhist +4,360‎ Jwarner talk contribs

m 02:27

Diffuse large B-cell lymphoma‎ diffhist +180‎ Jwarner talk contribs

24 May 2024

			m 13:43		Breast cancer‎‎ 6 changes history -18,104‎ [Jwarner‎ (6×)]
			m		13:43 (cur \| prev) 0‎ Jwarner talk contribs →‎Metastatic disease, first-line chemotherapy
			m		13:41 (cur \| prev) +148‎ Jwarner talk contribs →‎Adjuvant chemotherapy
			m		13:40 (cur \| prev) +96‎ Jwarner talk contribs →‎Adjuvant therapy, sequential regimens
			m		13:30 (cur \| prev) +1,190‎ Jwarner talk contribs →‎FEC {{#subobject:3613b7\|Regimen=1}}
			m		13:24 (cur \| prev) -19,616‎ Jwarner talk contribs →‎Cyclophosphamide & Doxorubicin (AC) {{#subobject:77b0fd\|Regimen=1}}
			m		11:21 (cur \| prev) +78‎ Jwarner talk contribs →‎References

m 01:16

Gastric cancer‎ diffhist +1,794‎ Jwarner talk contribs

			m 01:04		Melanoma‎‎ 3 changes history +1,697‎ [Jwarner‎ (3×)]
			m		01:04 (cur \| prev) -83‎ Jwarner talk contribs →‎Pembrolizumab monotherapy {{#subobject:0a3e71\|Regimen=1}}
			m		01:04 (cur \| prev) +499‎ Jwarner talk contribs →‎Neoadjuvant immunotherapy
			m		00:58 (cur \| prev) +1,281‎ Jwarner talk contribs →‎Pembrolizumab monotherapy {{#subobject:0a3e71\|Regimen=1}}

23 May 2024

m 13:37

Endometrial cancer‎ diffhist +636‎ Jwarner talk contribs →‎References